Wealthcare Capital Management’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
Other funds holding BMY
Wealthcare Capital Management's BMY Position: Q2 2021 in Review
Wealthcare Capital Management sold out of Bristol-Myers Squibb (BMY) in Q2 2021, closing a stake of 757 shares — an estimated $48K sold.
Wealthcare Capital Management first reported a position in BMY in Q2 2013 and held it in 25 quarters. The position peaked at $1.27M in Q1 2015. 2,370 funds tracked by Wall St. Rank hold BMY as of Q2 2021.
- Wealthcare Capital Management reported no remaining Bristol-Myers Squibb position as of Q2 2021 after selling out during the quarter.
- Wealthcare Capital Management sold 757 Bristol-Myers Squibb shares in Q2 2021, an estimated $48K.
- Wealthcare Capital Management first reported a position in Bristol-Myers Squibb in Q2 2013 and held it in 25 quarters.
- Wealthcare Capital Management's Bristol-Myers Squibb position peaked at $1.27M in Q1 2015.
- 2,370 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2021.
Based on Wealthcare Capital Management's 13F filing for Q2 2021, filed 16 Aug 2021.